Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (2.808.163 €): Multidisziplinäres europäisches Netzwerk für Forschung, Prävention und Kontrolle der COVID-19-Pandemie Hor16.03.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Multidisziplinäres europäisches Netzwerk für Forschung, Prävention und Kontrolle der COVID-19-Pandemie
I-MOVE-COVID-19 aims to obtain epidemiological, clinical and virological information about COVID-19 and patients infected with SARS-CoV-2, through provision of a flexible surveillance platform (adaptable to the epidemiological situation), research studies, hypothesis-testing and evaluation of public health interventions (e.g. vaccination, antivirals) in order to contribute to the knowledge base, guide patient management, and inform the public health response. This will be achieved through adaptation and expansion of the existing, long-running, Europe-wide influenza surveillance network (I-MOVE) to include COVID-19. The network includes primary care networks, hospitals, national laboratory reference centres in eleven countries. I-MOVE-COVID-19 priority activities and research projects will be selected based on ECDC/WHO input and the proposal’s detailed list. These will be conducted by mobilising an existing large European multidisciplinary network, combining the expertise and resources of groups working in surveillance (epidemiological, clinical, virological), respiratory disease research, and evaluation of vaccines/treatments. Through protocol sharing and pooling European results, questions will be answered which could not be efficiently answered by countries acting alone. I-MOVE-COVID-19 will share study results rapidly and widely with national and international partners and with the wider scientific community and contribute to clinical management of patients and public health preparedness and response to COVID-19.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Agence Nationale de Sante Publique | 0,00 € |
| Assistance Publique Hopitaux de Paris | 99.700 € |
| Centre Hospitalier Universitaire Montpellier | 28.200 € |
| 28.200 € | |
| 137.850 € | |
| Epiconcept | 509.063 € |
| Epiconcept UK Ltd. | 0,00 € |
| 90.350 € | |
| 0,00 € | |
| 0,00 € | |
| 0,00 € | |
| 109.350 € | |
| Hospices Civils de Lyon | 28.200 € |
| INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE | 187.150 € |
| Institut National de la Sante et de la Recherche Medicale | 2.500,00 € |
| Institut Pasteur | 79.000 € |
| 123.900 € | |
| 0,00 € | |
| 265.250 € | |
| 123.900 € | |
| 110.900 € | |
| 40.000 € | |
| 0,00 € | |
| 174.250 € | |
| 201.250 € | |
| 45.000 € | |
| Sorbonne Universite | 60.350 € |
| 140.350 € | |
| The Chancellor, Masters and Scholars of the University of Oxford | 59.000 € |
| Universite de Corse Pascal Paoli | 10.000,00 € |
| University of Strathclyde | 0,00 € |
| VACCINE SAFETY INITIATIVE VIVI e. V. | 92.450 € |
| Vrije Universiteit Brussel | 62.000 € |
Quelle: https://cordis.europa.eu/project/id/101003673
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "Agence Nationale de Sante Publique - EU-Förderung (2.808.163 €): Multidisziplinäres europäisches Netzwerk für Forschung, Prävention und Kontrolle der COVID-19-Pandemie"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
